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allele was associated with decreased plasma VB12 lev-
els (p = 0.036). In FABT, CBS rs2851391 was signifi-
cantly associated with CCA-IMT (p = 0.021) and CIMT 
(p = 0.019). In multi-level mixed-effects regression model, 
CBS rs2851391 was positively significantly associated 
with CCA-IMT (Coef = 0.032, se = 0.009, raw p < 0.001) 
after Bonferoni correction (corrected α = 0.0056). Gene–
gene interactions were found between CBS rs2851391 and 
BHMT rs10037045 for CCA-IMT (p = 0.011), as well as 
between CBS rs2851391 and MTR rs1805087 for CCA-
IMT (p = 0.007) and CIMT (p = 0.022). Significant asso-
ciations are found between Hcy metabolism related genetic 
polymorphisms, biochemical indexes and CIMT indexes. 
There are complex interactions between genetic polymor-
phisms for CCA-IMT and CIMT.
Keywords Homocysteine · Single nucleotide 
polymorphism · Carotid intima-media thickness · 
Atherosclerosis · Sib pair · Gene–gene interaction
Introduction
Carotid intima-media thickness (CIMT), a technique to 
monitor carotid artery wall alterations using ultrasonogra-
phy, is a noninvasive measurement of preclinical athero-
sclerosis [1]. It has often been considered as a surrogate of 
early atherosclerosis and is widely used for cardiovascular 
risk stratification [2].
Hyperhomocysteinemia is an independent risk factor for 
arteriosclerotic vascular diseases [3, 4]. However, the asso-
ciation between elevated plasma homocysteine (Hcy) and 
CIMT remains controversial [5]. This prompts the need for 
genetic association studies to investigate the involvement of 
Hcy in early stage of atherogenesis.
Abstract Carotid intima-media thickness (CIMT) is a 
good surrogate for atherosclerosis. Hyperhomocysteinemia 
is an independent risk factor for cardiovascular diseases. 
We aim to investigate the relationships between homo-
cysteine (Hcy) related biochemical indexes and CIMT, 
the associations between Hcy related SNPs and CIMT, 
as well as the potential gene–gene interactions. The pre-
sent study recruited full siblings (186 eligible families 
with 424 individuals) with no history of cardiovascular 
events from a rural area of Beijing. We examined CIMT, 
intima-media thickness for common carotid artery (CCA-
IMT) and carotid bifurcation, tested plasma levels for Hcy, 
vitamin B6 (VB6), vitamin B12 (VB12) and folic acid 
(FA), and genotyped 9 SNPs on MTHFR, MTR, MTRR, 
BHMT, SHMT1, CBS genes. Associations between SNPs 
and biochemical indexes and CIMT indexes were ana-
lyzed using family-based association test analysis. We 
used multi-level mixed-effects regression model to verify 
SNP-CIMT associations and to explore the potential gene–
gene interactions. VB6, VB12 and FA were negatively 
correlated with CIMT indexes (p < 0.05). rs2851391 T 
 * Yonghua Hu 
 yhhu@bjmu.edu.cn
1 Department of Epidemiology and Biostatistics, Peking 
University Health Science Center, 38 Xueyuan Road, 
Beijing 100191, China
2 Department of Epidemiology and Biostatistics, Capital 
Medical University, 10 You’anmenwai Xitoutiao, 
Beijing 100069, China
3 Beijing Center for Disease Prevention and Control, No.16 He 
Pingli Middle Street, Dongcheng District, Beijing 100013, 
China
4 Pingshan New District Center for Disease Control 
and Prevention, Shenzhen 518118, Guangdong, China
402 K. Sun et al.
1 3
Hcy can be influenced by genetic factors. Altered func-
tioning of catalytic enzymes in Hcy metabolic pathways 
caused by gene mutations may lead to inhibition of certain 
pathways and elevation of plasma Hcy level [6, 7]. Meth-
ylenetetrahydrofolate reductase (MTHFR), methionine 
synthase (MTR), methionines synthase reductase (MTRR), 
betaine-homocysteine methyltransferase (BHMT) are 
enzymes in Hcy remethylation pathway. Cystathionine-
β-synthase (CBS) is the key enzyme in Hcy transsulfura-
tion pathway. Serine hydroxymethyltransferase 1 (SHMT1) 
sequesters 5-methyltetrahydrofolate, a co-substrate for 
homocysteine remethylation, thus to inhibit Hcy metabo-
lism through methionine synthesis pathway. Genetic asso-
ciation studies between encoding genes of these enzymes 
and cardiovascular studies are previously studied [8, 9].
Different enzymes in Hcy metabolic pathways interact 
with each other. Complex interactions between variations 
of corresponding genes, especially interactions between 
functional polymorphisms, can contribute to Hcy metabolic 
disorder and subsequent diseases. Interactions between 
MTHFR 677 C>T (rs1801133) and CBS 844ins68 [10–
12], MTHFR 677 C>T and MTRR 66 A>G (rs1801394) 
[13] were found with regard to Hcy. Same interactions were 
shown to elevate neural tube defects risk [14]. However, the 
interactive effects of Hcy related SNPs on CIMT were not 
fully explored.
To investigate the associations between Hcy metabo-
lism related SNPs, Hcy related biochemical indexes and 
CIMT, we conducted a sib pair study in Chinese popula-
tion and genotyped 9 cardiovascular diseases associated 
SNPs on 6 Hcy metabolism related genes using candidate 
gene approach. The aims of the present study are: (1) to 
explore associations between SNPs and Hcy, vitamin B6 
(VB6), vitamin B12 (VB12), folic acid (FA) levels; (2) to 
test the associations between SNPs and CIMT indexes; (3) 




The current study nested in Fangshan Family-based 
Ischemic Stroke Study In China (FISSIC) program. FIS-
SIC has been described in details elsewhere [15]. In brief, 
it is an ongoing family-based genetic epidemiological study 
starting from June 2005. We recruited Northern Chinese 
Han pedigrees from communities in Fangshan District, Bei-
jing, China. The inclusion criteria for this study were: (1) 
>40 years old; (2) full siblings; (3) with no medical history 
of cardiovascular events (including angina pectoris, myo-
cardial infarction, sudden cardiac death, ischemic stroke, 
hemorrhagic stroke, transient ischemic attack, or other car-
diovascular diseases) or antihyperlipidemia treatment at 
base line. The exclusion criteria were: (1) receiving extra 
vitamin B or folic acid supplements regularly; (2) receiv-
ing drugs which can influence Hcy levels (methotrexated, 
isoniazide, azathioprine, thiazide diuretics); (3) incomplete 
genotyping data or other important parameters.
The present study included 186 eligible families with 
424 individuals. Written informed consent was obtained 
from every participant. This project was approved by the 
Ethics Committee of Peking University Health Science 
Center, Beijing, China.
Carotid intima-media thickness measurement
Every participant was scanned by one of the two trained 
ultrasonographers with high-resolution B-mode ultrasound 
system (Acuson Inc., Mountain View, CA, USA), using 
7.5- to 10.0-MHz linear transducers according to study 
protocol.
Bilateral carotid arteries were scanned from its origin 
to bifurcation in transverse plane through an anterolateral 
approach. Longitudinal views were obtained in three seg-
ments: (1) distal common carotid artery (CCA) (2  cm 
proximal to the dilatation of the carotid bulb); (2) proxi-
mal CCA (1  cm proximal to the dilatation of the carotid 
bulb); (3) bifurcation (1 cm proximal to the flow divider). 
The B-mode ultrasound images were recorded for at least 6 
cardiac cycles when the intimal–lumen interface of far wall 
was displayed as a sharp-edged continuous straight line.
IMT is a double-line pattern represented as the area 
between the artery luminal edge and media-adventitia 
interface [1]. IMT was analyzed by 3 qualified readers 
blinded to participants’ information using semi-automatic 
edge-detection software (Vasular Research Tool Carotid 
Analyzer, Medical Imaging Applications, Coralville, IA) 
in regions free of plaques. The mean IMT of far wall was 
recorded and was involved in further calculation. In each 
segment, we measured IMT both in diastole and systole 
frames and averaged the two values. The common carotid 
artery IMT (CCA-IMT) was the mean of 4 values obtained 
in bilateral distal and proximal CCA segments. The bifur-
cation IMT (Bif-IMT) was the mean of values in bilateral 
bifurcation segments. Carotid IMT (CIMT) was the mean 
of IMT in all segments.
To control the quality of IMT measurement, the reliabil-
ity of scanning and reading procedures was evaluated. The 
intra-class correlation coefficients for two sonographers 
were both over 0.93, while the inter-class correlation coef-
ficient was 0.90. The intra-reader correlation coefficients 
were 0.95 and 0.90 for CCA-IMT and Bif-IMT. The inter-
reader correlation coefficients were 0.88 and 0.86 for CCA-
IMT and Bif-IMT.
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Anthropometric measurements and biochemical 
analyses
The details of anthropometric measurements [including 
height (m), weight (kg), body mass index (BMI, kg/m2), 
systolic blood pressures (SBP, mmHg), diastolic blood 
pressures (DBP, mmHg), smoking status, drinking status] 
and biochemical analyses [fasting blood glucose (FBG, 
mmol/L), total cholesterol (TC, mmol/L), total triglycer-
ides (TG, mmol/L), high density lipoprotein cholesterol 
(HDL-C, mmol/L), low density lipoprotein cholesterol 
(LDL-C, mmol/L)] were described elsewhere [15]. Medi-
cal history of cardiovascular events was collected through 
local surveillance system consisting of community medi-
cal centers, township hospitals and district hospitals. Cur-
rent and ex-smokers were both treated as smokers during 
the analysis, as well as drinkers. Hypertension was defined 
as a diagnosis of hypertension, antihypertensive therapy, 
SBP ≥ 140 mmHg or DBP ≥ 90 mmHg during examination. 
Diabetes was defined as a diagnosis of diabetes, antidia-
betic therapy, or FBG ≥ 7.0 mmol/L.
Assessment of homocysteine, vitamin B6, vitamin B12 
and folic acid levels
We collected fasting venous blood sample from every par-
ticipant. Hcy (μmol/L) (Mindray, Shenzhen, China), VB6 
(pg/ml), VB12 (pg/ml), FA (pg/ml) (Cusabio, Wuhan, 
China) and plasminogen activator inhibitor-1 (PAI-1, pg/
ml) (Boster, Wuhan, China) concentrations were assessed 
by commercially available ELISA kits using TECAN 
GENios Plus enzyme-linked immunosorbent assay reader 
(TECAN, Grödig, Austria).
SNPs selection and genetic analysis
We investigated 9 single nucleotide polymorphisms (SNPs) 
in 6 well-studied candidate genes (MTHFR, MTR, MTRR, 
BHMT, SHMT1, CBS) involved in homocysteine metab-
olism. SNPs previously reported to be associated with 
homocysteine levels or cardiac-cerebral vascular diseases 
were selected.
DNA was extracted from blood samples. We performed 
DNA genotyping using MassARRAY iPLEX platform 
(Sequenom Inc, San Diego, California, USA) following the 
manufacturer’s protocol. We assessed SNP genotypes by 
MassARRAY Typer Analyzer version 4.0. The call rates 
for 9 SNPs were all above 99.0%. To verify reproducibility, 
a randomly chosen subgroup of 5% samples went through 
repeat analysis. The results of these duplicated samples 
were 100% consistent.
Statistical analysis
We analyzed TG, Hcy, VB6, VB12, FA, PAI-1 data on nat-
ural logarithmic scale owing to their skewed distribution. 
Continuous variables were described as the mean ± stand-
ard deviation and Student’s t test was adopted to compare 
means across gender groups. Categorical variables were 
described as frequency and proportion, and Pearson’s χ2 
test was used for comparisons between gender groups.
We investigated correlations between Hcy related bio-
chemical indexes and CIMT indexes, and the mean lev-
els of these biochemical indexes in every SNP genotype 
groups.
We estimated Hardy–Weinberg equilibrium (HWE) for 
SNPs in all participants and found no violation (Table 4). 
When investigated under additive genetic models, geno-
types with 0, 1 or 2 risk allele copies were coded as 0, 1 
and 2 respectively. When investigated under dominant 
genetic models, genotypes with 0 risk allele copies were 
coded as 0, while genotypes with 1 or 2 risk allele copies 
were coded as 1.
Family-based association test in genetic analyses 
(FBAT) is a method testing for linkage as well as associa-
tion using familial data. It is built on the original transmis-
sion disequilibrium test (TDT) method and is suitable for 
extended pedigrees such as sib pairs [16]. We used FBAT 
to estimate associations between SNPs and Hcy related bio-
chemical indexes, as well as CIMT indexes under additive 
models.
To replicate the significant findings in FBAT, we 
employed multi-level mixed-effects regression model, 
which can accommodate correlation between full siblings. 
Bonferoni-corrected α value was used as the level of sig-
nificance. SNPs with p < 0.05/9 = 0.0056 were considered 
significant.
We estimated gene–gene interactions between SNPs sig-
nificantly associated with CIMT indexes and other SNPs 
under dominant model by adding multiplicative terms in 
multi-level mixed-effects regression models.
FBAT analysis was conducted using PBAT software 
(v3.6). Other statistical analyses were performed by STATA 
(version 13, Stata Corporation, Texas, USA).
Results
Basic characteristics of participants and sib pairs
The correlations between CCA-IMT and Bif-IMT were 
0.754 and 0.786 in men and women respectively. Compared 
with males, females had lower rates of smoking and drink-
ing. Females also had lower SBP and DBP levels, as well 
as higher HDL-C levels. The CIMT indexes for females 
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were thinner. The prevalence of hypertension in females 
was lower than in males (Table 1).
Correlations between biochemical indexes and carotid 
intima-media thickness
VB6 (CCA-IMT: Corr = −0.283, p < 0.001; Bif-IMT: 
Corr = −0.234, p < 0.001; CIMT: Corr = −0.277, 
p < 0.001), VB12 (CCA-IMT: Corr = −0.194, p = 0.002; 
Bif-IMT: Corr = −0.173, p = 0.007; CIMT: Corr = −0.198, 
p = 0.002) and FA (CCA-IMT: Corr = −0.371, p < 0.001; 
Bif-IMT: Corr = −0.280, p < 0.001; CIMT: Corr = −0.363, 
p < 0.001); were negatively correlated with CIMT indexes. 
No correlations were found between Hcy, PAI-1 and CIMT 
indexes (Table 2).
Associations between homocysteine metabolism related 
SNPs and biochemical indexes
rs1801133 T allele was associated with elevated plasma 
Hcy levels (p = 0.012). rs1532268 A allele was associated 
with elevated plasma VB6 levels (p = 0.010). rs2851391 T 
allele was associated with decreased plasma VB12 levels 
(p = 0.036) (Table 3).
Associations between homocysteine metabolism 
related SNPs and carotid intima-media thickness 
in family-based association test analysis
When analyzing associations between 9 SNPs and 
CIMT indexes using family-based association test analy-
sis (FBAT), we found that CBS rs2851391 was signifi-
cantly associated with CCA-IMT (p = 0.021) and CIMT 
(p = 0.019), MTRR rs1532268 was significantly associated 
with CCA-IMT (p = 0.040). No significant association was 
found between Bif-IMT and homocysteine metabolism 
related SNPs (Table 4).
Table 1  Basic anthropometric characteristics of participants
Continuous variables were described as mean ± standard deviation. 
Categorical variables were described as frequency (proportion)
BMI body mass index, kg/m2; SBP systolic blood pressure, mmHg; 
DBP diastolic blood pressure, mmHg; FBG fast blood glucose, 
mmol/L; TC total cholesterol, mmol/L; TG total triglycerides, 
mmol/L; HDL-C high-density lipoprotein cholesterol, mmol/L; LDL-
C low-density lipoprotein cholesterol, mmol/L; Hcy homocysteine, 
μmol/L; VB6 vitamin B6, pg/ml; VB12 vitamin B12, pg/ml; FA folic 
acid, pg/ml; PAI-1 plasminogen activator inhibitor-1, pg/ml; CCA-
IMT common carotid artery intima-media thickness, mm; Bif-IMT 
bifurcation artery intima-media thickness, mm; CIMT carotid artery 
intima-media thickness, mm. TG, Hcy, VB6, VB12, FA, PAI-1 were 
analyzed on natural logarithmic scale
*p values for comparisons across different gender groups, ^p < 0.05
Total Male Female p*
n 424 237 (50.2) 187 (49.8) –
Age 53.9 ± 9.3 54.4 ± 9.5 53.2 ± 9.0 0.231
Smoking 185 (43.6) 164 (69.2) 21 (11.2) <0.001^
Drinking 131 (30.9) 117 (49.4) 14 (7.5) <0.001^
BMI 26.0 ± 3.5 25.9 ± 3.4 26.0 ± 3.7 0.733
SBP 136.4 ± 20.1 139.2 ± 19.0 133.6 ± 20.8 <0.001^
DBP 83.3 ± 11.8 85.5 ± 12.0 81.2 ± 11.2 <0.001^
FBG 5.69 ± 2.21 5.81 ± 2.24 5.57 ± 2.18 0.097
TC 3.76 ± 1.04 3.75 ± 1.01 3.77 ± 1.06 0.770
TG 0.37 ± 0.63 0.41 ± 0.64 0.31 ± 0.61 0.102
HDL-C 1.20 ± 0.43 1.17 ± 0.40 1.23 ± 0.45 0.046^
LDL-C 2.64 ± 0.67 2.65 ± 0.71 2.62 ± 0.63 0.661
Hcy 2.63 ± 0.46 2.67 ± 0.42 2.59 ± 0.50 0.182
VB6 9.09 ± 0.58 9.05 ± 0.58 9.13 ± 0.59 0.314
VB12 6.38 ± 0.60 6.38 ± 0.59 6.39 ± 0.60 0.867
FA 8.85 ± 0.51 8.85 ± 0.50 8.85 ± 0.52 0.966
PAI-1 11.58 ± 0.76 11.63 ± 0.67 11.52 ± 0.86 0.278
CCA-IMT 0.75 ± 0.01 0.77 ± 0.17 0.72 ± 0.01 0.002^
Bif-IMT 0.80 ± 0.18 0.82 ± 0.19 0.77 ± 0.15 0.004^
CIMT 0.76 ± 0.16 0.78 ± 0.17 0.73 ± 0.14 0.001^
Diabetes mel-
litus
73 (17.2) 42 (17.7) 31 (16.6) 0.757
Hypertension 250 (59.0) 156 (65.8) 94 (50.3) 0.003^
Table 2  Correlations between 
biochemical indexes and carotid 
intima-media thickness
Hcy homocysteine, VB6 vitamin B6, VB12 vitamin B12, FA folic acid, PAI-1 plasminogen activator inhibi-
tor-1, CCA-IMT common carotid artery intima-media thickness, Bif-IMT bifurcation artery intima-media 
thickness, CIMT carotid artery intima-media thickness, Corr correlation coefficient
^ p < 0.05
Variables CCA-IMT Bif-IMT CIMT
Corr p Corr p Corr p
Hcy 0.092 0.153 0.055 0.396 0.030 0.652
VB6 −0.283 <0.001^ −0.234 <0.001^ −0.277 <0.001^
VB12 −0.194 0.002^ −0.173 0.007^ −0.198 0.002^
FA −0.371 <0.001^ −0.280 <0.001^ −0.363 <0.001^
PAI-1 −0.011 0.861 0.012 0.848 −0.002 0.973
405Associations between homocysteine metabolism related SNPs and carotid intima-media thickness:…
1 3
Table 3  Associations between homocysteine metabolism related SNPs and biochemical indexes
*p for Family-based association test analysis under additive model, adjusting for age, sex, smoking, BMI, diabetes, SBP, TG, LDL-C, ^p < 0.05
SNP Geno-type Hcy VB6 VB12 FA PAI-1
Mean ± SD p* Mean ± SD p* Mean ± SD p* Mean ± SD p* Mean ± SD p*
rs1801133 CC 2.53 ± 0.50 0.012^ 9.13 ± 0.56 0.482 6.33 ± 0.59 0.906 8.87 ± 0.52 0.304 11.44 ± 0.91 0.524
CT 2.56 ± 0.40 9.04 ± 0.58 6.36 ± 0.64 8.86 ± 0.53 11.66 ± 0.58
TT 2.77 ± 0.46 9.27 ± 0.58 6.55 ± 0.51 8.86 ± 0.47 11.58 ± 0.58
rs1805087 AA 2.64 ± 0.45 0.947 9.15 ± 0.58 0.082 6.37 ± 0.62 0.877 8.88 ± 0.51 0.068 11.57 ± 0.69 0.382
AG 2.71 ± 0.45 8.88 ± 0.47 6.40 ± 0.52 8.70 ± 0.48 11.44 ± 1.03
GG 2.78 ± 0.76 8.86 ± 0.31 6.14 ± 0.29 8.63 ± 0.54 11.63 ± 0.78
rs16879248 TT 2.62 ± 0.45 0.391 9.06 ± 0.55 0.409 6.34 ± 0.58 0.886 8.88 ± 0.50 0.094 11.63 ± 0.67 0.898
TC 2.64 ± 0.51 9.05 ± 0.62 6.33 ± 0.61 8.76 ± 0.53 11.55 ± 0.83
CC 2.83 ± 0.52 9.51 ± 0.89 6.93 ± 0.69 8.92 ± 0.53 11.92 ± 0.34
rs1532268 GG 2.64 ± 0.48 0.299 9.07 ± 0.57 0.010^ 6.39 ± 0.61 0.364 8.86 ± 0.52 0.083 11.59 ± 0.75 0.786
GA 2.63 ± 0.42 9.08 ± 0.61 6.38 ± 0.52 8.75 ± 0.49 11.52 ± 0.78
AA 2.58 ± 0.24 9.15 ± 0.53 6.11 ± 0.84 9.12 ± 0.49 11.42 ± 1.05
rs10037045 AA 2.64 ± 0.42 0.535 9.11 ± 0.58 0.530 6.37 ± 0.62 0.639 8.85 ± 0.51 0.108 11.59 ± 0.75 0.242
AT 2.69 ± 0.52 9.10 ± 0.56 6.42 ± 0.57 8.90 ± 0.51 11.54 ± 0.76
TT 2.68 ± 0.45 9.07 ± 0.67 6.37 ± 0.61 8.82 ± 0.61 11.35 ± 0.62
rs3733890 GG 2.63 ± 0.43 0.573 9.09 ± 0.59 0.181 6.37 ± 0.61 0.692 8.83 ± 0.51 0.074 11.56 ± 0.76 0.315
GA 2.66 ± 0.52 9.03 ± 0.55 6.36 ± 0.58 8.85 ± 0.52 11.61 ± 0.77
AA 2.58 ± 0.49 9.13 ± 0.64 6.46 ± 0.59 8.84 ± 0.56 11.47 ± 0.68
rs11868708 TT 2.64 ± 0.47 0.543 9.11 ± 0.58 0.426 6.33 ± 0.59 0.158 8.87 ± 0.47 0.917 11.59 ± 0.81 0.565
TC 2.64 ± 0.47 9.03 ± 0.56 6.38 ± 0.57 8.83 ± 0.56 11.63 ± 0.64
CC 2.58 ± 0.45 9.05 ± 0.62 6.43 ± 0.69 8.84 ± 0.53 11.76 ± 0.30
rs2851391 CC 2.67 ± 0.47 0.426 9.14 ± 0.62 0.869 6.43 ± 0.61 0.036^ 8.88 ± 0.47 0.419 11.52 ± 0.76 0.284
CT 2.63 ± 0.43 9.09 ± 0.53 6.35 ± 0.60 8.84 ± 0.53 11.59 ± 0.76
TT 2.75 ± 0.46 9.05 ± 0.51 6.30 ± 0.61 8.90 ± 0.66 11.55 ± 0.61
rs234709 CC 2.64 ± 0.46 0.095 9.07 ± 0.59 0.273 6.42 ± 0.59 0.883 8.89 ± 0.51 0.053 11.56 ± 0.79 0.283
CT 2.54 ± 0.43 9.11 ± 0.59 6.35 ± 0.59 8.83 ± 0.52 11.72 ± 0.64
TT 2.88 ± 0.63 8.97 ± 0.60 5.9 ± 0.39 8.83 ± 0.69 11.46 ± 0.44
Table 4  Associations between homocysteine metabolism related SNPs and CIMT indexes in family-based association test analysis
Family-based association test analysis was under additive model, and adjusted for age, sex, smoking, BMI, diabetes, SBP, TG, LDL-C
HWE Hardy–Weinberg equilibrium, MAF minor allele frequency, described as minor allele (minor allele frequency)
# Fam: Numbers of informative families, ^p < 0.05
Gene SNP Location Alleles MAF HWE p value Fam# p for CCA-IMT p for Bif-IMT p for CIMT
MTHFR rs1801133 1:11796321 C/T T(0.379) 0.573 93 0.722 0.282 0.464
MTR rs1805087 1:236885200 A/G G(0.071) 0.765 22 0.839 0.873 0.875
MTRR rs16879248 5:7864419 T/C C(0.146) 0.784 47 0.855 0.970 0.903
MTRR rs1532268 5:7878066 G/A A(0.134) 0.866 46 0.040^ 0.453 0.133
BHMT rs10037045 5:79126747 A/T T(0.223) 0.246 68 0.111 0.095 0.066
BHMT rs3733890 5:79126136 G/A A(0.254) 0.819 76 0.078 0.102 0.056
SHMT1 rs11868708 17:18341299 T/C C(0.295) 0.289 77 0.130 0.829 0.287
CBS rs2851391 21:43067294 C/T T(0.295) 0.836 78 0.021^ 0.095 0.019^
CBS rs234709 21:43066854 C/T T(0.112) 0.651 38 0.562 0.314 0.388
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Associations between homocysteine metabolism related 
SNPs and carotid intima-media thickness in multi-level 
mixed-effects regression model
To replicate FBAT result, we further analyzed associa-
tions between 9 SNPs and CIMT indexes using multi-level 
mixed-effects regression model. SHMT1 rs11868708 was 
associated with CCA-IMT (Coef = 0.007, se = 0.008, 
raw p = 0.013) and CIMT (Coef = 0.011, se = 0.005, raw 
p = 0.024). CBS rs2851391was associated with CCA-
IMT (Coef = 0.032, se = 0.009, raw p < 0.001), Bif-IMT 
(Coef = 0.025, se = 0.011, raw p = 0.019) and CIMT 
(Coef = 0.023, se = 0.010, raw p = 0.018).
After Bonferoni correction, CBS rs2851391 remained 
significantly associated with CCA-IMT (α = 0.0056). 
Compared with individuals with no T alleles on 
rs2851391, every extra T allele can result in 0.032 
millimeters (mm) thickening of CIMT. No associations 
between SNPs and Bif-IMT or CIMT reached Bonferoni 
corrected α threshold (Table 5).
Gene–gene interactions between CBS rs2851391 
and other homocysteine related SNPs on carotid 
intima-media thickness
Gene–gene interactive effects were analyzed under domi-
nant genetic model in multi-level mixed-effects regression 
model. An interaction was found between CBS rs2851391 
and BHMT rs10037045 for CCA-IMT (p = 0.011). The 
combination of CBS rs2851391 CT/TT and BHMT 
rs10037045 AT/TT genotypes can increase CCA-IMT 
by 0.080  mm. Interactions were found between CBS 
rs2851391 and MTR rs1805087 for CCA-IMT (p = 0.007) 
and CIMT (p = 0.022). The combination of CBS rs2851391 
Table 5  Associations between homocysteine metabolism related SNPs and CIMT indexes in multi-level mixed-effects regression model
Coef coefficients, SE standard error
*Adjusting for age, sex, smoking, BMI, diabetes, SBP, TG, LDL-C
# Coefficients for SNPs in mixed models, ^p < 0.05, ^^p < 0.01
Gene SNP CCA-IMT Bif-IMT CIMT
Index changes 
per risk allele#
SE Raw p* Index changes 
per risk allele#
SE Raw p* Index changes 
per risk allele#
SE Raw p*
MTHFR rs1801133 0.007 0.008 0.374 0.008 0.010 0.434 0.007 0.009 0.438
MTR rs1805087 0.019 0.015 0.206 0.007 0.019 0.714 0.016 0.017 0.327
MTRR rs16879248 0.002 0.011 0.831 0.005 0.013 0.725 0.001 0.011 0.996
MTRR rs1532268 0.009 0.011 0.417 −0.001 0.013 0.959 0.004 0.012 0.723
BHMT rs10037045 0.002 0.009 0.835 0.007 0.011 0.493 0.008 0.010 0.425
BHMT rs3733890 −0.007 0.005 0.155 −0.002 0.006 0.769 −0.006 0.005 0.215
SHMT1 rs11868708 0.007 0.008 0.013^ 0.011 0.010 0.277 0.011 0.005 0.024^
CBS rs2851391 0.032 0.009 <0.001^^ 0.025 0.011 0.019^ 0.023 0.010 0.018^
CBS rs234709 0.005 0.007 0.503 −0.003 0.009 0.716 0.001 0.007 0.907
Table 6  Gene–gene interactive effects of homocysteine related SNPs on CIMT indexes
Adjusting for age, sex, smoking, BMI, diabetes, SBP, TG, LDL-C
a Coefficient for SNP1 in full mixed model
b Coefficient for SNP2 in full mixed model
c Sum of coefficients for SNP1, SNP2 and interaction term in full mixed model
^ p < 0.05, ^^p < 0.01
SNP Model CCA-IMT Bif-IMT CIMT
SNP1: CBS rs2851391 × SNP2: 
BHMT rs10037045
Index changes if risk allele of SNP1 existsa 0.051 0.042 0.043
Index changes if risk allele of SNP2 existsb −0.023 −0.003 −0.013
Index changes if risk alleles of both SNPs coexistc 0.080 0.061 0.075
p for interaction  0.011^ 0.402 0.052
SNP1: CBS 
rs2851391 × SNP2:MTR 
rs1805087
Index changes if risk allele of SNP1 existsa 0.042 0.039 0.035
Index changes if risk allele of SNP2 existsb −0.021 −0.011 −0.020
Index changes if risk alleles of both SNPs coexistc 0.101 0.073 0.089
p for interaction  0.007^^ 0.227  0.022^
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CT/TT and MTR rs1805087 AG/GG genotypes can 
increase CCA-IMT by 0.101 mm and CIMT by 0.089 mm 
(Table 6).
Discussion
The accessibility and reproducibility of CIMT measure-
ment varies significantly at different carotid artery segments 
[over 90% for CCA, 60–80% for bifurcation and 30–50% 
for internal carotid artery (ICA)] [17]. In the present study, 
we recorded images of bilateral ICA. However, ICA IMT 
can only be clearly measured in 38.6% participants. Thus 
it was not involved in further statistical analysis. The asso-
ciations between CIMT at various segments and cardiovas-
cular diseases are also different. Thickening of CCA-IMT 
may reflect the pathological changes of medial hypertrophy 
as a result of smooth muscle cell hyperplasia or fibrocel-
lular hypertrophy rather than the formation of atheroscle-
rotic plaque [18]. Epidemiological studies suggested CCA-
IMT as a strong predictor for cardiovascular events. It was 
associated with myocardial infarction and stroke [2, 19], 
which was later proved by a meta-analysis [20]. Carotid 
bifurcation is a region where blood in carotid artery flows 
into two vessels of unequal sizes. The consequent sudden 
changes of hemodynamic factors, such as variations in flow 
velocity, shear stress and turbulence, make carotid bifurca-
tion an atherosclerosis-prone location [21, 22]. Ebrahim 
et  al. reported that the associations between CCA-IMT 
and stroke were independent of carotid plaques, whereas 
associations between Bif-IMT and ischemic heart disease 
can be largely explained by the presence of carotid plaques 
[23].
B-group vitamins are essential coenzymes in Hcy 
metabolism. Evidences indicated that increased CIMT 
was associated with higher Hcy and lower folic acid levels 
[24]. Although we observed no associations between Hcy 
levels and CIMT indexes, significant negative associations 
between FA, VB6, VB12 and CIMT indexes were found in 
the present study. B vitamins (FA, VB6, VB12) can prevent 
atherogenesis through their antioxidant properties and their 
ability to lower plasma homocysteine levels [25, 26]. How-
ever, the effect of folic acid and vitamin B supplementation 
on CIMT progression was still controversial [27].
Plasminogen activator inhibitor-1, a component of the 
plasminogen/plasmin system, was considered as a link 
between inflammation, insulin resistance and vascular 
risks, such as atherogenesis and atherothrombosis [28, 29]. 
PAI-1 was suggested to be a predictor for cardiovascular 
disease [30]. However, associations between PAI-1 and 
CIMT were not consistent in different studies [31, 32]. We 
tested PAI-1 in the present study but found no associations 
between PAI-1 and CIMT indexes.
MTHFR 677 C>T (rs1801133) is the most frequently 
studied functional genetic polymorphism proved to be inde-
pendently associated with folate, homocysteine, and vascu-
lar endothelial dysfunction [33–35]. However, association 
between MTHFR 677 C>T genotype and CIMT in differ-
ent ethnic populations remains controversial [5, 36–38]. 
There is also no evidence that MTHFR 677 C>T has an 
effect on coronary artery disease [39]. In the present study, 
we observed an association between rs1801133 T allele 
and elevated plasma Hcy levels, but found null associa-
tion between MTHFR 677 C>T and CIMT indexes. These 
results indicated that the thickening of CIMT might be a 
pathological process resulting from complex metabolic dis-
orders rather than isolated hyperhomocysteinemia.
SHMT1 rs11868708 risk allele conferred a 1.46-fold 
risk of ischemic stroke in Singaporean Chinese. The total 
number of risk alleles on MTRR rs16879248, SHMT1 
rs11868708, TCN2 rs1173570 showed a cumulative effect 
on ischemic stroke [40]. These three SNPs were genotyped 
in the present study. The association between SHMT1 
rs11868708 and CCA-IMT (raw p = 0.013) didn’t reach 
Bonferoni corrected α threshold. More studies are needed 
to investigate the role SHMT1 rs11868708 plays in athero-
genesis and subsequent cardiovascular diseases.
Cystathionine-β-synthase (CBS) transforms homocyst-
eine to cystathionine in the assistance of vitamin B6. CBS 
68-bp insertion (844ins68) carriers have been reported to 
lower plasma Hcy levels [41]. Rs2851391 located in the 
intron of CBS. A GWAS meta-analysis showed that CBS 
rs234709 and CBS rs2851391 were associated with Hcy 
concentrations [9]. Zinck et  al. discussed that rs2851391 
variants might reduce the activity of CBS, and thus was 
positively associated with homocysteine levels [42]. 
Rs2851391 genetic polymorphism is associated with neural 
tube defects. Its risk genotype has a 2.0-fold risk of spina 
bifida [43]. Hsu et  al. indicated that rs2851391 polymor-
phisms were associated with changes in postmethionine 
load Hcy levels, but it was not associated with recurrent 
stroke risk [44]. In the present study, we identified CBS 
rs2851391 as a risk factor for CCA-IMT but not Bif-IMT. 
This might result from the different pathology for CCA-
IMT and Bif-IMT thickening. CBS rs2851391 T allele 
showed a marginal association with decreased plasma 
VB12 level, which might be a possible explanation for its 
association with CCA-IMT.
Methionine synthase (MTR) catalyzes the remethyla-
tion of homocysteine to methionine [45]. MTR rs1805087 
(A2756G) is a well-studied genetic polymorphism. Laraqui 
et al. defined Hcy level ≥15 μmol/l as hyperhomocyteine-
mia (HHcy), and found that MTR rs1805087 (A2756G) 
G allele contributed a 2.0-fold risk for HHcy [46]. The G 
allele can also increase DNA methylation level [47]. Masud 
et  al. reported significant associations of rs1805087 with 
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coronary artery disease under additive and dominant mod-
els [48].
Gene–gene interactions between homocysteine related 
SNPs are studied before. Many studies focus on interac-
tions between MTR rs1805087 and genetic polymorphisms 
of other homocysteine metabolism related genes. The com-
bination of MTR A2756G AG/GG, MTHFR 677 CT/TT 
and MTHFR 1298 AC/AA genotypes contributes signifi-
cantly to extremely high Hcy plasma levels [49]. Interac-
tion between MTR A2756G and MTRR A66G may lead 
to an increase of infants’ neural tube defects risks [50]. An 
existence of gene–gene interaction between rs1801133, 
rs662 and rs1805087 was reported for coronary artery 
disease [48]. MTR rs1805087 is located in the AdoMet-
binding region, this polymorphism results in a noncon-
servative substitution of aspartic acid residue by glycine 
residue, which could influence the secondary structure 
and function of the protein [51]. In the present study, we 
observed an association of distinct CBS rs2851391/MTR 
rs1805087 genotype combination with elevated CCA-IMT 
and CIMT, which might be an indication of interaction 
between Hcy remethylation pathway and transsulfuration 
pathway. BHMT rs10037045 is reported to be a risk fac-
tor for ischemic stroke [52]. This SNP is not well studied 
before. More researches are needed to understand the role 
BHMT rs10037045 plays in atherogenesis and cardiovas-
cular diseases, and its interaction with CBS rs2851391.
Compared with parent-offspring trios study, sib pair 
study is more suitable for late-onset diseases, since the par-
ents’ phenotypic and genotypic traits may not be available 
at the time offspring develops the certain disease. What’s 
more, sib pairs are more closely matched for age and envi-
ronmental factors than other relative pairs [53]. The shared 
genetic background for siblings from same pedigree pre-
vented the problem of population stratification, a cause for 
false positive associations in population based case-control 
studies. As a consequent, the power of sib pair study is rel-
atively low [54].
The present study has some limitations. Firstly, we only 
selected 9 SNPs located on homocysteine related genes 
using candidate gene approach. These 9 SNPs are previ-
ously reported to be associated with Hcy levels or cardio-
vascular diseases, or to have interactions with risk SNPs 
for cardiovascular diseases. Thus, the aim of the present 
family-based sib pair study is to verify positive results 
found in population based studies, rather than to identify 
new risk SNPs. Secondly, the present study is a cross-
sectional study. The causality of the associations is thus 
compromised. However, since human genetic profile is 
unchangeable during life time, the genetic risk factors can 
be considered as being prior to disease occurrence. On the 
other hand, this can’t deny the need for longitudinal stud-
ies to elucidate the relationships between homocysteine 
related SNPs and CIMT or CIMT changes. Thirdly, CIMT, 
especially CCA-IMT, is a good surrogate for cardiovascu-
lar events. The associations between risk SNPs and CIMT 
indexes suggest a possible influence of these SNPs on 
cardiovascular diseases. However, it is of greater value to 
directly elaborate the associations between SNPs and indi-
vidual diseases. FISSIC study is an ongoing family-based 
genetic epidemiological study. Our next goal is to investi-
gate the role genetic risk factors play in ischemic stroke, 
coronary artery disease and type 2 diabetes.
Conclusions
Significant associations are found between Hcy related 
genetic polymorphisms, biochemical indexes and carotid 
intema-media thickness. There are complex interactions 
between Hcy related genetic polymorphisms.
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